 NEW YORK and LONDON, March 30, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences. NASDAQ: TLSA; LSE: TILS, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, is pleased to confirm that, in order to finalise the distribution of shares in Accustem Sciences Limited Accustem to the holders of Tiziana shares in the US via its ADS program, it has recently filed a Form 20-F with the Securities Exchange Commission in the USA the SEC. The Form 20-F which gives full information about the business of Accustem, can be found at 